BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 19297508)

  • 1. Sensorimotor dysfunction in multiple sclerosis and column-specific magnetization transfer-imaging abnormalities in the spinal cord.
    Zackowski KM; Smith SA; Reich DS; Gordon-Lipkin E; Chodkowski BA; Sambandan DR; Shteyman M; Bastian AJ; van Zijl PC; Calabresi PA
    Brain; 2009 May; 132(Pt 5):1200-9. PubMed ID: 19297508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatial distribution of multiple sclerosis lesions in the cervical spinal cord.
    Eden D; Gros C; Badji A; Dupont SM; De Leener B; Maranzano J; Zhuoquiong R; Liu Y; Granberg T; Ouellette R; Stawiarz L; Hillert J; Talbott J; Bannier E; Kerbrat A; Edan G; Labauge P; Callot V; Pelletier J; Audoin B; Rasoanandrianina H; Brisset JC; Valsasina P; Rocca MA; Filippi M; Bakshi R; Tauhid S; Prados F; Yiannakas M; Kearney H; Ciccarelli O; Smith SA; Andrada Treaba C; Mainero C; Lefeuvre J; Reich DS; Nair G; Shepherd TM; Charlson E; Tachibana Y; Hori M; Kamiya K; Chougar L; Narayanan S; Cohen-Adad J
    Brain; 2019 Mar; 142(3):633-646. PubMed ID: 30715195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
    Agosta F; Absinta M; Sormani MP; Ghezzi A; Bertolotto A; Montanari E; Comi G; Filippi M
    Brain; 2007 Aug; 130(Pt 8):2211-9. PubMed ID: 17535835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinal cord grey matter abnormalities are associated with secondary progression and physical disability in multiple sclerosis.
    Kearney H; Schneider T; Yiannakas MC; Altmann DR; Wheeler-Kingshott CA; Ciccarelli O; Miller DH
    J Neurol Neurosurg Psychiatry; 2015 Jun; 86(6):608-14. PubMed ID: 25097217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis.
    Abdel-Aziz K; Schneider T; Solanky BS; Yiannakas MC; Altmann DR; Wheeler-Kingshott CA; Peters AL; Day BL; Thompson AJ; Ciccarelli O
    Brain; 2015 Jun; 138(Pt 6):1568-82. PubMed ID: 25863355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Grey matter involvement by focal cervical spinal cord lesions is associated with progressive multiple sclerosis.
    Kearney H; Miszkiel KA; Yiannakas MC; Altmann DR; Ciccarelli O; Miller DH
    Mult Scler; 2016 Jun; 22(7):910-20. PubMed ID: 26432854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative measures of walking and strength provide insight into brain corticospinal tract pathology in multiple sclerosis.
    Fritz NE; Keller J; Calabresi PA; Zackowski KM
    Neuroimage Clin; 2017; 14():490-498. PubMed ID: 28289599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of magnetization transfer ratio-derived pial and subpial abnormalities in the multiple sclerosis spinal cord.
    Kearney H; Yiannakas MC; Samson RS; Wheeler-Kingshott CA; Ciccarelli O; Miller DH
    Brain; 2014 Sep; 137(Pt 9):2456-68. PubMed ID: 24966048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiparametric MRI correlates of sensorimotor function in the spinal cord in multiple sclerosis.
    Oh J; Zackowski K; Chen M; Newsome S; Saidha S; Smith SA; Diener-West M; Prince J; Jones CK; Van Zijl PC; Calabresi PA; Reich DS
    Mult Scler; 2013 Apr; 19(4):427-35. PubMed ID: 22891033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms.
    Nijeholt GJ; van Walderveen MA; Castelijns JA; van Waesberghe JH; Polman C; Scheltens P; Rosier PF; Jongen PJ; Barkhof F
    Brain; 1998 Apr; 121 ( Pt 4)():687-97. PubMed ID: 9577394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative spinal cord MRI in MOG-antibody disease, neuromyelitis optica and multiple sclerosis.
    Mariano R; Messina S; Roca-Fernandez A; Leite MI; Kong Y; Palace JA
    Brain; 2021 Feb; 144(1):198-212. PubMed ID: 33206944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinal cord spectroscopy and diffusion-based tractography to assess acute disability in multiple sclerosis.
    Ciccarelli O; Wheeler-Kingshott CA; McLean MA; Cercignani M; Wimpey K; Miller DH; Thompson AJ
    Brain; 2007 Aug; 130(Pt 8):2220-31. PubMed ID: 17664178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker.
    Kolind S; Seddigh A; Combes A; Russell-Schulz B; Tam R; Yogendrakumar V; Deoni S; Sibtain NA; Traboulsee A; Williams SC; Barker GJ; Brex PA
    Neuroimage Clin; 2015; 9():574-80. PubMed ID: 26594633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical cord area is associated with infratentorial grey and white matter volume predominantly in relapsing-remitting multiple sclerosis: A study using semi-automated cord volumetry and voxel-based morphometry.
    Bellenberg B; Schneider R; Weiler F; Suchan B; Haghikia A; Hoffjan S; Gold R; Köster O; Lukas C
    Mult Scler Relat Disord; 2015 May; 4(3):264-72. PubMed ID: 26008944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships between quantitative spinal cord MRI and retinal layers in multiple sclerosis.
    Oh J; Sotirchos ES; Saidha S; Whetstone A; Chen M; Newsome SD; Zackowski K; Balcer LJ; Frohman E; Prince J; Diener-West M; Reich DS; Calabresi PA
    Neurology; 2015 Feb; 84(7):720-8. PubMed ID: 25609766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 7 T imaging reveals a gradient in spinal cord lesion distribution in multiple sclerosis.
    Ouellette R; Treaba CA; Granberg T; Herranz E; Barletta V; Mehndiratta A; De Leener B; Tauhid S; Yousuf F; Dupont SM; Klawiter EC; Sloane JA; Bakshi R; Cohen-Adad J; Mainero C
    Brain; 2020 Oct; 143(10):2973-2987. PubMed ID: 32935834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetization transfer ratio of the spinal cord in multiple sclerosis: relationship to atrophy and neurologic disability.
    Lycklama à Nijeholt GJ; Castelijns JA; Lazeron RH; van Waesberghe JH; Polman CH; Uitdehaag BM; Barkhof F
    J Neuroimaging; 2000 Apr; 10(2):67-72. PubMed ID: 10800258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis.
    Rovaris M; Bozzali M; Santuccio G; Ghezzi A; Caputo D; Montanari E; Bertolotto A; Bergamaschi R; Capra R; Mancardi G; Martinelli V; Comi G; Filippi M
    Brain; 2001 Dec; 124(Pt 12):2540-9. PubMed ID: 11701606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetization transfer ratio abnormalities reflect clinically relevant grey matter damage in multiple sclerosis.
    Fisniku LK; Altmann DR; Cercignani M; Tozer DJ; Chard DT; Jackson JS; Miszkiel KA; Schmierer K; Thompson AJ; Miller DH
    Mult Scler; 2009 Jun; 15(6):668-77. PubMed ID: 19435751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease duration.
    Kearney H; Rocca MA; Valsasina P; Balk L; Sastre-Garriga J; Reinhardt J; Ruggieri S; Rovira A; Stippich C; Kappos L; Sprenger T; Tortorella P; Rovaris M; Gasperini C; Montalban X; Geurts JJ; Polman CH; Barkhof F; Filippi M; Altmann DR; Ciccarelli O; Miller DH; Chard DT
    Mult Scler; 2014 Jan; 20(1):72-80. PubMed ID: 23812283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.